Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating coronary heart diseases and preparation method of medicine composition

A composition and coronary heart disease technology, which is applied in the direction of drug combination, pharmaceutical formula, cardiovascular system diseases, etc., can solve the problems of high incidence of coronary heart disease, high manufacturing cost, complicated preparation process, etc.

Inactive Publication Date: 2013-04-10
姜永芳
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Coronary heart disease is called "the first killer of human beings" because of its high incidence rate and high mortality rate, which seriously endangers human health. After searching, it is found that the application number 01100351.0 discloses a nano-stimulant drug and its preparation method, but the preparation process is complicated and the manufacturing cost is high; the active ingredients in each raw material drug will be destroyed during the microwave extraction process; its original public application document does not give clinical information or prove its curative effect
At present, there is no other Chinese patent medicine that effectively treats chest tightness, angina pectoris, high blood pressure, dizziness, headache, neck pain, arrhythmia, and hyperlipidemia caused by qi stagnation and blood stasis type coronary heart disease.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating coronary heart diseases and preparation method of medicine composition
  • Medicine composition for treating coronary heart diseases and preparation method of medicine composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Raw materials: Panax notoginseng 100g, Danshen 100g, Ligusticum chuanxiong 50g, Safflower 50g, Dalbergia odorifera 50g;

[0054] Preparation:

[0055] ① Crush Panax notoginseng and Salvia miltiorrhiza into fine powder and pass through an 80 mesh sieve;

[0056] ②Cut Dalbergia odorifera and Ligusticum chuanxiong into slices, extract the volatile oil, collect the volatile oil, and save it in another container;

[0057] ③Decoct Dalbergia odorifera, Chuanxiong medicinal residue and safflower with 6 times the amount of water for three times, the first time is 2 hours, the second and third time are both 1.5 hours, filtered, and concentrated under reduced pressure to the relative density at 60℃ 1.15~1.20 extract;

[0058] ④Add the above-mentioned fine powder of Panax notoginseng and Salvia miltiorrhiza to the extract obtained in step ③, mix well, granulate, spray into the volatile oil obtained in step ②, and dry at 60°C to prepare granules.

Embodiment 2

[0060] Raw materials: Panax notoginseng 200g, Danshen 200g, Ligusticum chuanxiong 100g, Safflower 100g, Dalbergia odorifera 100g;

[0061] Preparation:

[0062] ① Crush Panax notoginseng and Salvia miltiorrhiza into fine powder and pass through an 80 mesh sieve;

[0063] ②Cut Dalbergia odorifera and Ligusticum chuanxiong into slices, extract the volatile oil, collect the volatile oil, and save it in another container;

[0064] ③Decoct Dalbergia odorifera, Chuanxiong medicinal residue and safflower with 6 times the amount of water for three times, the first time is 2 hours, the second and third time are both 1.5 hours, filtered, and concentrated under reduced pressure to the relative density at 60℃ 1.15~1.20 extract;

[0065] ④Add the above-mentioned Panax Notoginseng and Salvia miltiorrhiza fine powder to the extract obtained in step ③, mix and granulate, and spray into the volatile oil obtained in step ②, dry at 60°C, pulverize, and compress into tablets.

Embodiment 3

[0067] Raw materials: Panax notoginseng 150g, Danshen 150g, Ligusticum chuanxiong 75g, Safflower 75g, Dalbergia odorifera 75g;

[0068] Preparation:

[0069] ① Crush Panax notoginseng and Salvia miltiorrhiza into fine powder and pass through an 80 mesh sieve;

[0070] ②Cut Dalbergia odorifera and Ligusticum chuanxiong into slices, extract the volatile oil, collect the volatile oil, and save it in another container;

[0071] ③Decoct Dalbergia odorifera, Chuanxiong medicinal residue and safflower with 6 times the amount of water for three times, the first time is 2 hours, the second and third time are both 1.5 hours, filtered, and concentrated under reduced pressure to the relative density at 60℃ 1.15~1.20 extract;

[0072] ④Add the above-mentioned Panax Notoginseng and Salvia miltiorrhiza fine powder to the extract obtained in step ③, mix and granulate, and spray into the volatile oil obtained in step ②, dry at 60°C, pulverize, and fill capsules to make capsules.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine composition for treating coronary heart diseases and a preparation method of the medicine composition. The medicine is prepared from raw materials including pseudo-ginseng, salvia miltiorrhiza, ligusticum wallichii, safflower and dalbergia wood through processing, the efficacies of promoting blood circulation to remove blood stasis and promoting qi circulation to relieve pain are realized, and the medicine is clinically used for treating the coronary heart diseases.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a medicine for treating symptoms such as chest tightness, angina pectoris, high blood pressure, dizziness, headache, neck pain, arrhythmia, and hyperlipidemia caused by qi stagnation and blood stasis type coronary heart disease Compositions and methods for their preparation. Background technique [0002] Coronary heart disease is short for coronary heart disease. It is a kind of myocardial ischemia hypoxia or necrosis caused by coronary circulatory disturbance due to fixed (atherosclerosis) or dynamic (vasospasm) stenosis or obstruction, which causes an imbalance between myocardial oxygen supply and demand. A heart disease, also known as ischemic heart disease. [0003] The incidence of coronary heart disease increases with age, and the degree also increases with age. According to data, starting from the age of 40, the prevalence rate of coronary heart disease will double for ev...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/537A61P9/10
Inventor 姜永芳
Owner 姜永芳
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com